The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?

Ambulatory Gas Usage in Patients With Chronic Obstructive Pulmonary Disease and Exertional Hypoxemia

(2013) Mika L. Nonoyama et al.   Journal of Cardiopulmonary Rehabilitation and Prevention

Circulating Nucleic Acids as a Potential Source for Cancer Biomarkers

(2010) V. Vlassov et al.   CURRENT MOLECULAR MEDICINE

Using Science to Improve the Nation's Health System

(2010) Michael S. Lauer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations

(2010) Deborah R. Zucker et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Using N-of-1 Trials to Improve Patient Management and Save Costs

(2010) Paul A. Scuffham et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

The Path to Personalized Medicine

(2010) Margaret A. Hamburg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Opportunities for Research and NIH

(2010) F. S. Collins   SCIENCE

Pharmacy Benefit Managers, Pharmacies, and Pharmacogenomic Testing: Prescription for Progress?

(2010) E. J. Topol   Science Translational Medicine

Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention

(2009) Lutz E Kraushaar et al.   BMC PUBLIC HEALTH

Clinically Available Pharmacogenomics Tests

(2009) DA Flockhart et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Marketing therapeutic precision: Potential facilitators and barriers to adoption of n-of-1 trials

(2009) Richard L. Kravitz et al.   Contemporary Clinical Trials

Using N-of-1 Trials in Evidence-Based Clinical Practice

(2009) Apostolos Tsapas   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Policy Debate over Public Investment in Comparative Effectiveness Research

(2009) Eugene C. Rich   JOURNAL OF GENERAL INTERNAL MEDICINE

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

(2009) Eric Van Cutsem et al.   NEW ENGLAND JOURNAL OF MEDICINE

New Era of Personalized Medicine: A 10-Year Anniversary

(2009) J. T. Jorgensen   ONCOLOGIST

Prioritising drugs for single patient (n-of-1) trials in palliative care

(2009) J. Nikles et al.   PALLIATIVE MEDICINE

Genomic and personalized medicine: foundations and applications

(2009) Geoffrey S. Ginsburg et al.   Translational Research

Perspective: Prospective Health Care and the Role of Academic Medicine: Lead, Follow, or Get Out of the Way

(2008) Ralph Snyderman et al.   ACADEMIC MEDICINE

Are we approaching the post-blockbuster era? Pharmacodiagnostics and rational drug development

(2008) Jan Trøst Jørgensen   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

What Ever Happened to N-of-1 Trials? Insiders' Perspectives and a Look to the Future

(2008) RICHARD L. KRAVITZ et al.   MILBANK QUARTERLY

n of 1 trial for an ornithine transcarbamylase deficiency carrier

(2008) A. Hackett et al.   MOLECULAR GENETICS AND METABOLISM

A mobile phone program to track young people’s experiences of mood, stress and coping

(2008) Sophie C. Reid et al.   SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY

Auricall®. A new device for a non-invasive, wireless, continuous monitoring of oxygen saturation and heart rate in patients with heart failure

(2007) Isabella Sudano et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

An N-of-1 Trial as an Aid to Decision-Making Prior to Implanting a Permanent Spinal Cord Stimulator

(2007) M. Soledad Cepeda et al.   PAIN MEDICINE

Are N-of-1 Trials an Economically Viable Option to Improve Access to Selected High Cost Medications? The Australian Experience

(2007) Paul A. Scuffham et al.   VALUE IN HEALTH